{"abstract": "Johnson & Johnson said last night that it would record a $440 million write-down to account for declining revenue from its heart-failure infusion treatment, Natrecor.", "web_url": "https://www.nytimes.com/2007/11/30/business/30heart.html", "snippet": "Johnson & Johnson said last night that it would record a $440 million write-down to account for declining revenue from its heart-failure infusion treatment, Natrecor.", "lead_paragraph": "Johnson & Johnson said last night that it would record a $440 million write-down to account for declining revenue from its heart-failure infusion treatment, Natrecor.", "print_section": "C", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "Drop in Sales of a Drug Leads to a Write-Down", "kicker": null, "content_kicker": null, "print_headline": "Drop in Sales of a Drug Leads to a Write-Down", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Johnson & Johnson Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Heart", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Sales", "rank": 4, "major": "N"}], "pub_date": "2007-11-30T05:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By The New York Times", "person": [], "organization": "The New York Times"}, "type_of_material": "News", "_id": "nyt://article/b9572753-d016-59bd-9ed9-55cb2c875a48", "word_count": 148, "uri": "nyt://article/b9572753-d016-59bd-9ed9-55cb2c875a48"}